General Information of the Compound
Compound ID |
CP0454555
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4-fluoro-1-spiro[6H-benzo[b][1]benzoxepine-5,3'-cyclopentane]-1'-ylpiperidine-4-carboxylic acid
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C24H26FNO3
|
||||||||||||||||||
Molecular Weight |
395.474
|
||||||||||||||||||
Canonical SMILES |
OC(=O)C1(F)CCN(CC1)C1CCC2(C1)Cc1ccccc1Oc1ccccc21
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C24H26FNO3/c25-24(22(27)28)11-13-26(14-12-24)18-9-10-23(16-18)15-17-5-1-3-7-20(17)29-21-8-4-2-6-19(21)23/h1-8,18H,9-16H2,(H,27,28)
Show/Hide
|
||||||||||||||||||
InChIKey |
DBFNYFZBHMQFLI-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Protein ID: PT01206, Histamine H1 receptor